Premier Raises Concerns Over CMS’ CY 2027 Medicare Outpatient Payment Proposal While Supporting Efforts to Strengthen Domestic Healthcare Supply Chains
Premier Inc. has expressed significant concern regarding the Centers for Medicare & Medicaid Services (CMS) proposed rule for the Calendar Year (CY) 2027 Medicare Outpatient Prospective Payment System (OPPS), warning that several of the agency’s proposed reimbursement changes could place additional financial pressure on hospitals already facing rising operating costs and challenging economic conditions.
In a statement responding to the proposed rule, Premier argued that while certain provisions—particularly those encouraging stronger domestic healthcare supply chains—represent positive steps forward, the overall payment proposal does not adequately reflect the financial realities confronting hospitals across the United States.
According to the healthcare improvement company, the combined impact of the proposed payment update and several additional reimbursement policies could significantly reduce Medicare revenue for many hospitals, potentially affecting their ability to maintain services, invest in workforce development, and continue caring for vulnerable patient populations.
Proposed Payment Update Falls Short of Hospital Cost Growth
One of Premier’s primary concerns centers on the proposed 2.4% increase to Medicare outpatient payment rates under the CY 2027 OPPS rule.
While CMS typically updates Medicare reimbursement annually to account for inflation and changes in healthcare delivery costs, Premier contends that the proposed adjustment remains insufficient to match the actual expenses hospitals continue to experience.
Healthcare organizations nationwide have faced sustained increases in labor costs, pharmaceutical spending, medical supplies, equipment purchases, utilities, cybersecurity investments, and infrastructure maintenance over the past several years.
Hospital leaders have consistently argued that Medicare payment updates should better reflect these rising expenses to ensure providers can continue delivering high-quality care without compromising financial stability.
Premier believes the proposed payment increase fails to adequately account for the true cost of operating modern healthcare facilities.
Financial Pressures Continue Across the Hospital Sector
Hospitals throughout the country continue operating in a complex financial environment shaped by multiple long-term challenges.
Although patient volumes have recovered in many areas following disruptions experienced during the COVID-19 pandemic, providers continue managing elevated labor costs driven by workforce shortages, competitive hiring markets, and increasing reliance on contract staffing.
Supply chain disruptions have also contributed to higher prices for pharmaceuticals, medical devices, surgical supplies, and essential equipment.
In addition, hospitals continue investing heavily in digital health technologies, cybersecurity protections, electronic health record modernization, quality improvement initiatives, regulatory compliance, and capital infrastructure projects.
Many healthcare organizations, particularly rural hospitals and safety-net providers, have reported persistent operating margin pressures despite ongoing efforts to improve efficiency.
Premier argues that Medicare reimbursement policies should recognize these continuing economic realities.
Concerns Over Expanded Site-Neutral Payment Policies
In addition to the annual payment update, Premier expressed concern regarding CMS’ proposal to further expand site-neutral payment policies.
Site-neutral payment reforms generally seek to reduce differences in Medicare reimbursement for similar outpatient services delivered in different care settings, such as hospital outpatient departments and physician offices.
Supporters argue that site-neutral payments reduce unnecessary spending and create greater consistency across healthcare settings.
However, many hospital organizations contend that outpatient departments incur significantly higher operational costs because they must maintain emergency preparedness, comply with extensive regulatory requirements, provide around-the-clock services, and care for medically complex patient populations.
Premier cautioned that expanding site-neutral payment reductions could disproportionately affect hospitals already facing financial challenges while limiting resources available to support comprehensive outpatient care.
The organization believes policymakers should carefully evaluate the broader impact of such reimbursement changes before implementation.
Proposed 340B Policy Changes Raise Additional Concerns
Another major area of concern involves CMS proposals affecting the 340B Drug Pricing Program.
The 340B program allows eligible hospitals and healthcare organizations serving vulnerable populations to purchase outpatient medications at discounted prices, enabling them to stretch limited resources while supporting services for underserved communities.
Premier noted that the proposed rule includes both an acceleration of existing 340B recoupment policies and additional proposals that could substantially reduce Medicare reimbursement associated with the program.
According to the organization, these combined changes could significantly offset the proposed payment increase and effectively push many hospitals into negative reimbursement territory.
Hospitals participating in the 340B program often use resulting savings to expand patient assistance programs, improve access to specialty care, support rural healthcare services, and finance community health initiatives.
Premier warned that substantial reimbursement reductions could weaken hospitals’ ability to sustain these important programs.
Cumulative Financial Impact
Rather than evaluating each policy independently, Premier emphasized the importance of considering the cumulative financial impact of all proposed reimbursement changes contained within the CY 2027 rule.
Although the annual payment update may appear positive in isolation, the organization argues that additional reductions associated with site-neutral payment expansion and 340B reimbursement changes collectively diminish the overall payment increase.
For some providers, Premier believes these combined policies could result in an overall reduction in Medicare reimbursement despite the nominal payment update.
Such financial pressures may affect hospitals’ capacity to recruit healthcare professionals, maintain specialized clinical services, invest in advanced technologies, and expand patient access to care.
The organization therefore urged CMS to carefully assess how multiple policy changes interact before finalizing the rule.
Support for Domestic Supply Chain Initiatives
Despite its concerns regarding reimbursement policy, Premier welcomed several aspects of the proposed rule related to strengthening domestic healthcare supply chains.
The company praised CMS for seeking additional public feedback regarding policies intended to encourage procurement of American-made personal protective equipment (PPE) and essential medicines.
The COVID-19 pandemic exposed significant vulnerabilities within global healthcare supply chains, highlighting dependence on overseas manufacturing for many critical medical products.
Since then, healthcare organizations, policymakers, and industry leaders have increasingly advocated for expanding domestic production capacity to improve national preparedness for future public health emergencies.
Premier has been among the leading organizations promoting initiatives that strengthen U.S.-based manufacturing of medical supplies and pharmaceuticals.
Recognizing the Cost of Domestic Manufacturing
Premier also expressed appreciation that CMS acknowledged hospitals may incur higher costs when purchasing domestically manufactured PPE and essential medications.
Although American-made healthcare products can improve supply chain reliability and reduce dependence on foreign suppliers, domestic manufacturing frequently carries higher production costs.
Hospitals committed to purchasing U.S.-manufactured products may therefore face increased procurement expenses compared with imported alternatives.
Premier believes Medicare policies should recognize these additional costs and consider reimbursement approaches that encourage healthcare organizations to prioritize resilient domestic supply chains without creating financial disadvantages.
Such incentives could support both national healthcare security and long-term manufacturing investment.
Building a More Resilient Healthcare System
The organization emphasized that resilient healthcare supply chains extend beyond routine purchasing decisions.
Reliable access to PPE, pharmaceuticals, medical devices, and critical healthcare supplies has become a strategic priority following recent global disruptions.
Premier has consistently advocated for policies that diversify manufacturing capacity, increase domestic production, improve supply chain transparency, strengthen inventory management, and reduce dependence on single-source suppliers.
The company believes these efforts are essential not only for responding to future emergencies but also for maintaining continuity of routine patient care.
CMS’ continued attention to supply chain resilience represents an encouraging development that Premier hopes will lead to practical policy solutions.
Commitment to Collaboration
While criticizing several reimbursement proposals, Premier also reaffirmed its willingness to work collaboratively with CMS throughout the rulemaking process.
Federal agencies routinely solicit public comments on proposed Medicare payment regulations before issuing final rules.
Healthcare organizations, hospitals, physician groups, manufacturers, patient advocacy organizations, and other stakeholders use this opportunity to provide feedback regarding potential operational, financial, and clinical implications.
Premier indicated that it intends to actively engage with CMS by offering recommendations aimed at balancing fiscal responsibility with hospitals’ need for sustainable reimbursement.
The organization expressed optimism that constructive dialogue could help refine several aspects of the proposed rule before implementation.
Importance of Sustainable Hospital Financing
Adequate Medicare reimbursement remains a critical issue for hospitals because Medicare beneficiaries account for a substantial portion of patient volume across many healthcare systems.
Payment rates influence hospitals’ ability to invest in workforce recruitment, facility modernization, technology adoption, quality improvement initiatives, clinical innovation, and community health programs.
Many hospitals—particularly rural facilities, teaching hospitals, and safety-net institutions—operate with narrow financial margins while serving populations with complex healthcare needs.
Premier argues that reimbursement policies should support long-term financial sustainability while ensuring continued patient access to comprehensive outpatient services.
Balancing healthcare affordability with provider stability remains one of the central challenges facing Medicare policymakers.
As CMS continues reviewing stakeholder feedback on the CY 2027 Medicare Outpatient Prospective Payment System proposed rule, Premier is urging the agency to reconsider several reimbursement provisions that it believes could further strain hospital finances. While the organization welcomes CMS’ interest in promoting stronger domestic manufacturing and more resilient healthcare supply chains, it cautions that the combined impact of the proposed payment update, expanded site-neutral payment policies, and changes to the 340B Drug Pricing Program could significantly reduce Medicare reimbursement for many providers.
Premier maintains that hospitals require reimbursement policies that more accurately reflect rising operating costs while supporting continued investment in patient care, workforce development, technology, and community health services. At the same time, the organization remains committed to working collaboratively with CMS to develop practical policy solutions that strengthen both America’s healthcare delivery system and its medical supply chain for the future.
Source link: https://premierinc.com/
